Atlas Trials

Testing the Addition of Ivonescimab Combined With Standard Chemotherapy Compared to the Usual Chemotherapy and Immunotherapy Treatment for Patients With Advanced Biliary Tract Cancer

Clinical trial NCT07765433 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07765433
Sponsor
ECOG-ACRIN Cancer Research Group
Status
NOT_YET_RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Locally Advanced Biliary Tract AdenocarcinomaLocally Advanced Extrahepatic CholangiocarcinomaLocally Advanced Intrahepatic CholangiocarcinomaLocally Advanced Unresectable Gallbladder AdenocarcinomaMetastatic Biliary Tract AdenocarcinomaMetastatic Extrahepatic CholangiocarcinomaMetastatic Gallbladder AdenocarcinomaMetastatic Intrahepatic CholangiocarcinomaStage III Distal Bile Duct Cancer AJCC v8Stage III Intrahepatic Cholangiocarcinoma AJCC v8Stage IV Distal Bile Duct Cancer AJCC v8Stage IV Intrahepatic Cholangiocarcinoma AJCC v8
Start date
2027-01-11
Primary completion
2028-12-31
Enrollment
336

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.